American Kestrel (Falco sparverius)
American Kestrel (Falco sparverius)
Exposure Endpoint Type | Endpoint Value | Endpoint Description | Units | Life Cycle Stage | Sample Size | Location | Type | Countries | Error |
---|---|---|---|---|---|---|---|---|---|
Dietary Composition | Vertebrates (29.1 %) Arthropods (70.9 %) | Frequency determined by pellet analysis | Frequency, % | Fledgling | 19 fledglings | Parque Luro Reserve | Exposure Factor Datasets | ARGENTINA | |
Dietary Composition | Vertebrates (11.2 %) Arthropods (88.8 %) | Frequency determined by prey remains | Frequency, % | Fledgling | 19 fledglings | Parque Luro Reserve | Exposure Factor Datasets | ARGENTINA | |
Time of Mating/ Laying | Late October-late December | Adult | 6 nests | Parque Luro Reserve | Exposure Factor Datasets | ARGENTINA | |||
Clutch or Litter Size | 4.3 | eggs | Embryo | 6 nests | Parque Luro Reserve | Exposure Factor Datasets | ARGENTINA | 0.3 | |
Hatching Success | 0.73 | Embryo | 26 eggs | Parque Luro Reserve | Exposure Factor Datasets | ARGENTINA |
Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Sample Size | Location | Type | Lab |
---|---|---|---|---|---|---|---|---|
PARATHION | 47% decrease at 4.6 ppm | mean brain cholinesterase activity relative to control | Not Reported | Adult | 4/group | Toxicity Factor Datasets | Laboratory | |
PARATHION | 56% decrease at 4.6 ppm | mean plasma cholinesterase activity relative to control | Not Reported | Adult | 4/group | Toxicity Factor Datasets | Laboratory |
Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Sample Size | Location | Type | Lab |
---|---|---|---|---|---|---|---|---|
LEAD (elemental) | increase at 50 ppm 1.3 ppm (1.00 SD) males; 2.4 ppm (1.40 SD) females |
mean lead concentration in liver | Both Male and Female | Adult | 16 pairs/group | Toxicity Factor Datasets | Laboratory | |
LEAD (elemental) | no effect | mean organ and carcass weights | Both Male and Female | Adult | 16 pairs/dose | Toxicity Factor Datasets | Laboratory |
Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Sample Size | Location | Type | Lab |
---|---|---|---|---|---|---|---|---|
METHYLPARATHION | increase at 3 mg/kg bw | mortality rate 2 hr post-dose | Both Male and Female | Adult | 5/dose | Toxicity Factor Datasets | Laboratory | |
METHYLPARATHION | decrease at 2, 3 mg/kg bw | cloacal temperature | Both Male and Female | Adult | 5/dose | Toxicity Factor Datasets | Laboratory | |
METHYLPARATHION | decrease at 2, 3 mg/kg bw | plasma cholinesterase activity 2 hr post-dose | Both Male and Female | Adult | 5/dose | Toxicity Factor Datasets | Laboratory | |
METHYLPARATHION | decrease at 1, 2, 3 mg/kg bw | brain acetylcholinesterase activity 10 hr post-dose | Both Male and Female | Adult | 5/dose | Toxicity Factor Datasets | Laboratory | |
METHYLPARATHION | increased at 2, 3 mg/kg bw | plasma glucose concentrations | Both Male and Female | Adult | 5/dose | Toxicity Factor Datasets | Laboratory |
Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Sample Size | Location | Type |
---|---|---|---|---|---|---|---|
CARBOFURAN | 3 | number of dead kestrels found on treated fields | Not Reported | Not Reported | 44 fields | Toxicity Factor Datasets | |
CARBOFURAN | 1.7-7.4 ppm (wet wt) | carcass residues of kestrels found dead | Not Reported | Not Reported | 3 birds | Toxicity Factor Datasets |
Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Sample Size | Location | Type | Lab |
---|---|---|---|---|---|---|---|---|
DDE (4,4'-) | 507-877.1 ppm (dry wt) | liver residues in birds that died | Male | Adult | 2 | Toxicity Factor Datasets | Laboratory | |
DDE (4,4'-) | 88.1 ppm (dry wt) | mean liver residues in birds that survived | Male | Adult | 11 | Toxicity Factor Datasets | Laboratory |
Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Sample Size | Location | Type |
---|---|---|---|---|---|---|---|
DDT (Technical Grade Mixture) | 0.78 ppm | mean DDT concentration in plasma of birds sampled 0-1.5 mi from sprayed area | Both Male and Female | Adult | 23 birds | La Grande-Enterprise (OR), Potlatch (ID) | Toxicity Factor Datasets |
Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Sample Size | Location | Type | Lab |
---|---|---|---|---|---|---|---|---|
AROCLOR 1254, MIREX | 20.3% decrease @ 8 ppm mirex + 33 ppm Aroclor | sperm concentration | Male | Adult | 5-10/group | Toxicity Factor Datasets | Laboratory | |
AROCLOR 1254, MIREX | no effect | sperm motility | Male | Adult | 5-10/group | Toxicity Factor Datasets | Laboratory |
Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Sample Size | Location | Type | Lab |
---|---|---|---|---|---|---|---|---|
PHOSPHORUS (YELLOW OR WHITE) | increased | accumulation in skin | Not Reported | Adult | 4/group | Toxicity Factor Datasets | Laboratory | |
PHOSPHORUS (YELLOW OR WHITE) | no effect | occurence of phosphorus intoxication symptoms | Not Reported | Adult | 4/group | Toxicity Factor Datasets | Laboratory |
Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Sample Size | Location | Type | Lab |
---|---|---|---|---|---|---|---|---|
SELENOMETHIONINE | Y=1.132 + 0.801X (R^2 = 0.932) | relationship between Se concentrations in diet and blood | Both Male and Female | Adult | 9-10 pairs/group | Toxicity Factor Datasets | Laboratory | |
SELENIUM COMPOUNDS | 7.5 ppm Se, dry wt | maximum observed Se concentration in blood | Both Male and Female | Adult | 10 pairs/group | Toxicity Factor Datasets | Laboratory | |
SELENOMETHIONINE | no effect | incidence of mortality or signs of toxicity | Both Male and Female | Adult | 9-10 pairs/group | Toxicity Factor Datasets | Laboratory |
Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Sample Size | Location | Type | Age-Specific | Lab |
---|---|---|---|---|---|---|---|---|---|
PCB 126 (3,3',4,4',5-PENTACHLOROBIPHENYL) | positive correlation | relationship between hepatic PCB 126 concentrations and ratio of oxidized to reduced glutathione | Not Reported | Nestling | 9-11/group | Toxicity Factor Datasets | Day 1-Day 10 | Laboratory |
Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Sample Size | Location | Type | Lab |
---|---|---|---|---|---|---|---|---|
SELENOMETHIONINE | increased @ 6 or 12 ppm Se | food consumption versus controls | Both Male and Female | Adult | 15 pairs/treatment group; 10 control pairs | Toxicity Factor Datasets | Laboratory | |
SELENOMETHIONINE | no effect | percent of pairs that laid eggs, number of fertile pairs and egg hatchability versus controls | Both Male and Female | Adult | 15 pairs/treatment group; 10 control pairs | Toxicity Factor Datasets | Laboratory | |
SELENOMETHIONINE | no effect | egg mass, width, length, and volume versus controls | Both Male and Female | Adult | 15 pairs/treatment group; 10 control pairs | Toxicity Factor Datasets | Laboratory | |
SELENOMETHIONINE | reduced @ 12 ppm Se | ratio of # fertile eggs to total # eggs laid versus 6 ppm Se group | Both Male and Female | Adult | 15 pairs/treatment group; 10 control pairs | Toxicity Factor Datasets | Laboratory | |
SELENOMETHIONINE | no effect | incidence of embryo deformities versus controls | Both Male and Female | Adult | 15 pairs/treatment group; 10 control pairs | Toxicity Factor Datasets | Laboratory | |
SELENOMETHIONINE | no effect | chick mass and size at hatch, and chick survival to fledging versus controls | Both Male and Female | Adult, Juvenile | 15 pairs/treatment group; 10 control pairs | Toxicity Factor Datasets | Laboratory |
Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Sample Size | Location | Type | Age-Specific | Lab |
---|---|---|---|---|---|---|---|---|---|
FLUORIDE, SODIUM | 247.0 +/- 103.1 ppm @ 0 ppm; 6137.9 +/- 823.8 ppm @ 1120 ppm; 10,272.6 +/- 865.8 ppm @ 2240 ppm | mean fluoride content in the diaphyses of femurae | Both Male and Female | Juvenile | 9-10/group | Toxicity Factor Datasets | 7 d | Laboratory | |
FLUORIDE, SODIUM | no effect | growth of body weight and skeletal components (skull, bill, tarsus, antebrachium, and manus) | Both Male and Female | Juvenile | 9-10/group | Toxicity Factor Datasets | 7 d | Laboratory | |
FLUORIDE, SODIUM | increased at 1120, 2240 ppm | % bone ash | Both Male and Female | Juvenile | 9-10/group | Toxicity Factor Datasets | 7 d | Laboratory | |
FLUORIDE, SODIUM | decreased at 2240 ppm | bonebreaking strength | Both Male and Female | Juvenile | 9-10/group | Toxicity Factor Datasets | 7 d | Laboratory |
Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Sample Size | Location | Type | Age-Specific | Lab |
---|---|---|---|---|---|---|---|---|---|
PCB 126 (3,3',4,4',5-PENTACHLOROBIPHENYL) | reduced @ 233 ng/g | percent hatching success, percent pipped versus controls | Not Reported | Hatchling | 24-26/treatment group | Toxicity Factor Datasets | hatchling | Laboratory | |
PCB 126 (3,3',4,4',5-PENTACHLOROBIPHENYL) | reduced @ 233 ng/g | liver weight, radius and femur length versus controls | Not Reported | Hatchling | 24-26/treatment group | Toxicity Factor Datasets | hatchling | Laboratory | |
PCB 126 (3,3',4,4',5-PENTACHLOROBIPHENYL) | increased @ 2.3, 23, 233 ng/g | incidence of malformations or edema, and EROD activity versus controls | Not Reported | Hatchling | 24-26/treatment group | Toxicity Factor Datasets | hatchling | Laboratory | |
PCB 77 (3,3',4,4'-TETRACHLOROBIPHENYL) | reduced @ 100, 1000 ng/g | percent hatching success, percent pipped versus controls | Not Reported | Hatchling | 24-26/treatment group | Toxicity Factor Datasets | hatchling | Laboratory | |
PCB 77 (3,3',4,4'-TETRACHLOROBIPHENYL) | reduced @ 1000 ng/g | humerus length versus controls | Not Reported | Hatchling | 24-26/treatment group | Toxicity Factor Datasets | hatchling | Laboratory | |
PCB 77 (3,3',4,4'-TETRACHLOROBIPHENYL) | increased @ 100, 1000 ng/g | incidence of malformations or edema, and EROD activity versus controls | Not Reported | Hatchling | 24-26/treatment group | Toxicity Factor Datasets | hatchling | Laboratory |
Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Sample Size | Location | Type | Lab |
---|---|---|---|---|---|---|---|---|
LEAD (elemental) | 31% decrease at 625 mg/kg bw 14% decrease at 125 mg/kg bw |
hematocrit | Both Male and Female | Nestling | 10/group | Toxicity Factor Datasets | Laboratory | |
LEAD (elemental) | 48% decrease at 625 mg/kg bw 27% decrease at 125 mg/kg bw 12% decrease at 25 mg/kg bw |
red blood cell hemoglobin content | Both Male and Female | Nestling | 10/group | Toxicity Factor Datasets | Laboratory | |
LEAD (elemental) | decrease at all doses (45-59%) | red blood cell delta aminolevulinic acid dehydratase | Both Male and Female | Nestling | 10/group | Toxicity Factor Datasets | Laboratory | |
LEAD (elemental) | 30% decrease at 625 mg/kg bw 25% decrease at 125 mg/kg bw |
plasma creatine phosphokinase | Both Male and Female | Nestling | 10/group | Toxicity Factor Datasets | Laboratory | |
LEAD (elemental) | decrease at 125, 625 mg/kg bw (47-57%) | brain delta aminolevulinic acid dehydratase activity | Both Male and Female | Nestling | 10/group | Toxicity Factor Datasets | Laboratory | |
LEAD (elemental) | decrease at 125, 625 mg/kg bw (71-79%) | kidney delta aminolevulinic acid dehydratase activity | Both Male and Female | Nestling | 10/group | Toxicity Factor Datasets | Laboratory | |
LEAD (elemental) | decrease at 125, 625 mg/kg bw (20-25%) | liver delta aminolevulinic acid dehydratase activity | Both Male and Female | Nestling | 10/group | Toxicity Factor Datasets | Laboratory |
Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Sample Size | Location | Type | Age-Specific | Lab |
---|---|---|---|---|---|---|---|---|---|
LEAD COMPOUNDS | 1.13 ppm blood at 212 ppm; 1.69 ppm blood at 448 ppm | mean lead concentration in blood | Both Male and Female | Adult | 8-14/group | Toxicity Factor Datasets | 1-2 yr | Laboratory | |
LEAD COMPOUNDS | 7.84 ppm femur at 120 ppm; 16.60 ppm femur at 212 ppm; 18.44 ppm femur at 448 ppm | mean lead concentration in femur | Both Male and Female | Adult | 8-14/group | Toxicity Factor Datasets | 1-2 yr | Laboratory | |
LEAD COMPOUNDS | no effect | packed cell volume, hemoglogin concentration, erythrocyte counts | Both Male and Female | Adult | 8-14/group | Toxicity Factor Datasets | 1-2 yr | Laboratory |
Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Sample Size | Location | Type | Lab |
---|---|---|---|---|---|---|---|---|
DDE (4,4'-) | no effect | variance in kestrel response time to prey stimulus | Not Reported | Adult | 6 | Toxicity Factor Datasets | Laboratory | |
DDE (4,4'-) | 1.37 (0.10 SE) mg/kg | mean DDE concentration in blood (wet wt) | Not Reported | Adult | 6 | Toxicity Factor Datasets | Laboratory |
Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Sample Size | Location | Type |
---|---|---|---|---|---|---|---|
DDE (4,4'-) | 10% decrease | eggshell thickness change relative to control | Female | Adult | 34 eggs | Cayuga Lake Basin | Toxicity Factor Datasets |
Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Sample Size | Location | Type | Lab |
---|---|---|---|---|---|---|---|---|
AROCLOR 1254, POLYCHLORINATED DIBENZO-P-DIOXINS | increased @ 0.5, 5 ppm | in vitro microsomal breakdown of oestradiol | Both Male and Female | Adult | 4/group | Toxicity Factor Datasets | Laboratory | |
AROCLOR 1262, POLYCHLORINATED DIBENZO-P-DIOXINS | increased @ 0.5, 5 ppm | in vitro microsomal breakdown of oestradiol | Both Male and Female | Adult | 4/group | Toxicity Factor Datasets | Laboratory | |
AROCLOR 1254, POLYCHLORINATED DIBENZO-P-DIOXINS | increased @ 5 ppm | amount of liver cytoplasmic RNA | Both Male and Female | Adult | 4/group | Toxicity Factor Datasets | Laboratory |
Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Sample Size | Location | Type | Lab |
---|---|---|---|---|---|---|---|---|
PARAQUAT | 22% @ 10 mg/kg, 18% @ 25 mg/kg, 44% @ 60 mg/kg | percent mortality | Not Reported | Juvenile | 11/group | Toxicity Factor Datasets | Laboratory | |
PARAQUAT | 86% of control @ 25 mg/kg, 74% of control @ 60 mg/kg | body weight by 10 days of dosing | Not Reported | Juvenile | 11/group | Toxicity Factor Datasets | Laboratory | |
PARAQUAT | 11% @ 25 mg/kg, 25% @ 60 mg/kg | percent increase over controls in brain to body weight ratio | Not Reported | Juvenile | 11/group | Toxicity Factor Datasets | Laboratory | |
PARAQUAT | 14% @ 25 mg/kg, 18% @ 60 mg/kg | percent increase over controls in liver to body weight ratio | Not Reported | Juvenile | 11/group | Toxicity Factor Datasets | Laboratory | |
PARAQUAT | 51% @ 60 mg/kg | percent increase over controls in kidney to body weight ratio | Not Reported | Juvenile | 11/group | Toxicity Factor Datasets | Laboratory | |
PARAQUAT | no effect | percent increase over controls in lung to body weight ratio | Not Reported | Juvenile | 11/group | Toxicity Factor Datasets | Laboratory | |
PARAQUAT | decreased @ 25, 60 mg/kg | skeletal growth (humerus, femur, radius-ulna, tibia-fibula) | Not Reported | Juvenile | 11/group | Toxicity Factor Datasets | Laboratory |
Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Sample Size | Location | Type | Lab |
---|---|---|---|---|---|---|---|---|
FENTHION | 100% | Male | Adult | 14 | Toxicity Factor Datasets | Laboratory | ||
FENTHION | 77.9-92% | range of brain acetylcholinesterase inhibition (relative to control) in birds that died | Male | Adult | 14 | Toxicity Factor Datasets | Laboratory | |
FENTHION | 96% | range of plasma cholinesterase inhibition (relative to control) in birds that died | Male | Adult | 14 | Toxicity Factor Datasets | Laboratory |
Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Sample Size | Location | Type | Lab |
---|---|---|---|---|---|---|---|---|
DICOFOL | decreased 5.45% (@ 5 mg/kg), 10.98% (@ 20 mg/kg) | eggshell thickness compared to controls | Female | Adult | 10/group | Toxicity Factor Datasets | Laboratory | |
DICOFOL | non-detectable (@ 5 mg/kg), 560 ng/g (@ 20 mg/kg) | mean concentration of metabolite dichlorobenzophenone in eggs | Female | Adult | 10/group | Toxicity Factor Datasets | Laboratory | |
DICOFOL | increased @ 5 and 20 mg/kg | incidence of abnormal embyronic gonads | Both Male and Female | Embryo | 10/group | Toxicity Factor Datasets | Laboratory | |
DICOFOL | increased @ 5 mg/kg | numbers of chicks or eggs lost (destroyed) by breeding male and female offspring of dicofol-treated females versus controls | Female | Adult | 10/group | Toxicity Factor Datasets | Laboratory | |
DICOFOL | no effect | eggshell thickness for breeding female offspring of dicofol-treated females versus controls | Female | Adult | 10/group | Toxicity Factor Datasets | Laboratory | |
DICOFOL | increased @ 5 mg/kg bw | incidence of abnormal gonads in male offspring of dicofol-treated females versus controls | Male | Adult | 10/group | Toxicity Factor Datasets | Laboratory |
Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Sample Size | Location | Type | Lab |
---|---|---|---|---|---|---|---|---|
DDE (4,4'-) | decrease at 10 ppm | mean eggshell thickness | Female | Adult | 8-10 | Toxicity Factor Datasets | Laboratory | |
DDE (4,4'-) | 0.71 (0.05 SE) ppm at 0 ppm, 32.4 (2.78 SE) ppm at 10 ppm |
mean residues in eggs | Female | Embryo | 9-10 | Toxicity Factor Datasets | Laboratory |
Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Sample Size | Location | Type | Lab |
---|---|---|---|---|---|---|---|---|
DIMETHYLMERCURY | no effect | eggshell thickness | Female | Adult | Not Reported | Toxicity Factor Datasets | Laboratory |
Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Sample Size | Location | Type | Lab |
---|---|---|---|---|---|---|---|---|
ACEPHATE, DDE (4,4'-) | no effect | prey capturing behavior | Not Reported | Adult | 5-6/group | Toxicity Factor Datasets | Laboratory | |
ACEPHATE, DDE (4,4'-) | decrease for both treatments | median serum cholinesterase activity 24 hr post-dose | Not Reported | Adult | 5-6/group | Toxicity Factor Datasets | Laboratory |
Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Sample Size | Location | Type | Age-Specific | Lab |
---|---|---|---|---|---|---|---|---|---|
PCB 105 (2,3,3',4,4'-PENTACHLOROBIPHENYL), PCB 126 (3,3',4,4',5-PENTACHLOROBIPHENYL), PCB 153 (2,2',4,4',5,5'-HEXACHLOROBIPHENYL) | increased with PCB 153 | aminopyrine N-demethylase and aldrin epoxidase activities in liver | Female | Adult | 5-6/group | Toxicity Factor Datasets | 1 yr | Laboratory | |
PCB 105 (2,3,3',4,4'-PENTACHLOROBIPHENYL), PCB 126 (3,3',4,4',5-PENTACHLOROBIPHENYL), PCB 153 (2,2',4,4',5,5'-HEXACHLOROBIPHENYL) | increased with PCB 105 | aminopyrine N-demethylase activity in liver | Female | Adult | 5-6/group | Toxicity Factor Datasets | 1 yr | Laboratory | |
PCB 105 (2,3,3',4,4'-PENTACHLOROBIPHENYL), PCB 126 (3,3',4,4',5-PENTACHLOROBIPHENYL), PCB 153 (2,2',4,4',5,5'-HEXACHLOROBIPHENYL) | increased with PCB 126 | 7-ethoxyresorufin O-deethylase and aldrin epoxidase activities in liver | Female | Adult | 5-6/group | Toxicity Factor Datasets | 1 yr | Laboratory | |
PCB 105 (2,3,3',4,4'-PENTACHLOROBIPHENYL), PCB 126 (3,3',4,4',5-PENTACHLOROBIPHENYL), PCB 153 (2,2',4,4',5,5'-HEXACHLOROBIPHENYL) | no effect | hepatic porphyrin levels | Female | Adult | 5-6/group | Toxicity Factor Datasets | 1 yr | Laboratory |
Chemical | Endpoint Value | Location | Type |
---|---|---|---|
POLYCHLORINATED BIPHENYLS | review | Toxicity Factor Datasets |
Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Sample Size | Location | Type | Lab |
---|---|---|---|---|---|---|---|---|
DDE (4,4'-) | decrease | eggshell thickness | Female | Adult | 8/group | Toxicity Factor Datasets | Laboratory | |
DDE (4,4'-) | decrease | Calcium ATPase activity of shell gland | Female | Adult | 8/group | Toxicity Factor Datasets | Laboratory | |
DDE (4,4'-) | decrease | carbonic anhydrase activity of shell gland | Female | Adult | 8/group | Toxicity Factor Datasets | Laboratory |
Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Sample Size | Location | Type | Lab |
---|---|---|---|---|---|---|---|---|
DDE (4,4'-) | decrease at 3 ppm | mean eggshell thickness | Female | Adult | 18 | Toxicity Factor Datasets | Laboratory |
Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Sample Size | Location | Type |
---|---|---|---|---|---|---|---|
LEAD COMPOUNDS | 0.24 ug/g at study area, 0.087 ug/g at reference area |
mean lead concentration in blood (wet wt) | Both Male and Female | Nestling | 30 (study area) 22 (reference) |
Coeur D'Alene River | Toxicity Factor Datasets |
LEAD COMPOUNDS | 0.46 ug/g at study area 0.25 ug/g at reference area |
mean lead concentration in blood (wet wt) | Both Male and Female | Adult | 3 (study area) 6 (reference) |
Coeur D'Alene River | Toxicity Factor Datasets |
LEAD COMPOUNDS | decreased | red blood cell delta aminolevulinic acid dehydratase activity (relative to control) | Both Male and Female | Both Adults and Juveniles | 33 | Coeur D'Alene River | Toxicity Factor Datasets |
Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Sample Size | Location | Type | Lab |
---|---|---|---|---|---|---|---|---|
CYANIDE, SODIUM | 4.0 mg/kg bw | LD50 | Both Male and Female | Adult | 5/dose | Toxicity Factor Datasets | Laboratory |
Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Sample Size | Location | Type | Lab |
---|---|---|---|---|---|---|---|---|
DDE (4,4'-), DIELDRIN, LEAD COMPOUNDS | 1.05 (0.05 SE) ppm (wet wt) | lead concentration in liver | Female | Juvenile | 2 | Toxicity Factor Datasets | Laboratory | |
DDE (4,4'-), DIELDRIN, LEAD COMPOUNDS | 0.70 (0.20 SE) ppm (wet wt) | lead concentration in tibia | Female | Juvenile | 2 | Toxicity Factor Datasets | Laboratory |
Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Sample Size | Location | Type | Lab |
---|---|---|---|---|---|---|---|---|
EPN | 4.0 mg/kg bw (3.1-5.1 95% CI) | LD50 | Both Male and Female | Adult | 5/group | Toxicity Factor Datasets | Laboratory | |
FENTHION | 1.4 mg/kg bw | LD50 | Both Male and Female | Adult | 5/group | Toxicity Factor Datasets | Laboratory |
Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Sample Size | Location | Type | Lab |
---|---|---|---|---|---|---|---|---|
AROCLOR 1248 | 18.5 ug/g (5.1SD), PCBs; 0.10 ug/g (0.03 SD), dieldrin;1.02 ug/g (0.39 SD), DDE @ 3.0 ug/g | mean carcass concentrations, wet wt | Both Male and Female | Adult | 8 pairs/group | Toxicity Factor Datasets | Laboratory | |
AROCLOR 1248 | 5% decrease @ 3.0 ug/g | mean eggshell thickness | Female | Adult | 8 pairs/group | Toxicity Factor Datasets | Laboratory |
Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Sample Size | Location | Type | Lab |
---|---|---|---|---|---|---|---|---|
AROCLOR 1254, PCB 126 (3,3',4,4',5-PENTACHLOROBIPHENYL), PCB 153 (2,2',4,4',5,5'-HEXACHLOROBIPHENYL), PCB 77 (3,3',4,4'-TETRACHLOROBIPHENYL) | increased with PCB 77 | liver weight (as percent of body weight) versus controls | Female | Adult | 4/treatment group | Toxicity Factor Datasets | Laboratory |